The Innate Immune Cell Profile of the Cornea Predicts the Onset of Ocular Surface Inflammatory Disorders.

autoimmune diseases conjunctiva dendritic cells inflammation lymphocytes ocular surface disease

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
02 Dec 2019
Historique:
received: 16 10 2019
revised: 26 11 2019
accepted: 29 11 2019
entrez: 8 12 2019
pubmed: 8 12 2019
medline: 8 12 2019
Statut: epublish

Résumé

Ocular surface inflammatory disorder (OSID) is a spectrum of disorders that have features of several etiologies whilst displaying similar phenotypic signs of ocular inflammation. They are complicated disorders with underlying mechanisms related to several autoimmune disorders, such as rheumatoid arthritis (RA), Sjögren's syndrome, and systemic lupus erythematosus (SLE). Current literature shows the involvement of both innate and adaptive arms of the immune system in ocular surface inflammation. The ocular surface contains distinct components of the immune system in the conjunctiva and the cornea. The normal conjunctiva epithelium and sub-epithelial stroma contains resident immune cells, such as T cells, B cells (adaptive), dendritic cells, and macrophages (innate). The relative sterile environment of the cornea is achieved by the tolerogenic properties of dendritic cells in the conjunctiva, the presence of regulatory lymphocytes, and the existence of soluble immunosuppressive factors, such as the transforming growth factor (TGF)-β and macrophage migration inhibitory factors. With the presence of both innate and adaptive immune system components, it is intriguing to investigate the most important leukocyte population in the ocular surface, which is involved in immune surveillance. Our meta-analysis investigates into this with a focus on both infectious (contact lens wear, corneal graft rejection, Cytomegalovirus, keratitis, scleritis, ocular surgery) and non-infectious (dry eye disease, glaucoma, graft-vs-host disease, Sjögren's syndrome) situations. We have found the predominance of dendritic cells in ocular surface diseases, along with the Th-related cytokines. Our goal is to improve the knowledge of immune cells in OSID and to open new dimensions in the field. The purpose of this study is not to limit ourselves in the ocular system, but to investigate the importance of dendritic cells in the disorders of other mucosal organs (e.g., lungs, gut, uterus). Holistically, we want to investigate if this is a common trend in the initiation of any disease related to the mucosal organs and find a unified therapeutic approach. In addition, we want to show the power of computational approaches to foster a collaboration between computational and biological science.

Identifiants

pubmed: 31810226
pii: jcm8122110
doi: 10.3390/jcm8122110
pmc: PMC6947418
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Exp Optom. 2017 Jan;100(1):33-40
pubmed: 27353750
Korean J Intern Med. 2018 May;33(3):483-489
pubmed: 29502361
Br J Ophthalmol. 2007 Jan;91(1):29-32
pubmed: 16943231
Int J Mol Sci. 2018 Sep 14;19(9):null
pubmed: 30223431
Curr Eye Res. 2018 Apr;43(4):487-492
pubmed: 29286836
Cornea. 2011 Apr;30(4):379-87
pubmed: 21045640
Nutr Diabetes. 2017 Mar 20;7(3):e251
pubmed: 28319106
J Fr Ophtalmol. 2006 Feb;29(2):121-6
pubmed: 16523152
Ocul Immunol Inflamm. 2018;26(8):1219-1222
pubmed: 28910561
J Immunol. 1999 Aug 15;163(4):2226-35
pubmed: 10438965
Front Immunol. 2015 Mar 23;6:129
pubmed: 25852695
Indian J Ophthalmol. 2018 Jan;66(1):39-43
pubmed: 29283120
J Exp Med. 2012 Apr 9;209(4):653-60
pubmed: 22430490
PLoS One. 2013;8(2):e57557
pubmed: 23451242
Blood. 2012 Aug 9;120(6):1237-45
pubmed: 22760781
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7179-85
pubmed: 26540656
Ophthalmology. 1991 Nov;98(11):1720-6
pubmed: 1839324
Trends Immunol. 2013 Nov;34(11):521-30
pubmed: 23973621
Cornea. 2010 Jan;29(1):43-52
pubmed: 19907292
Pediatr Res. 2009 May;65(5 Pt 2):26R-31R
pubmed: 19218879
PLoS One. 2017 Apr 5;12(4):e0173301
pubmed: 28379971
Mol Med Rep. 2015 Feb;11(2):1384-90
pubmed: 25351602
Sci Rep. 2017 Sep 6;7(1):10720
pubmed: 28878217
J Autoimmun. 2018 Feb;87:50-60
pubmed: 29371049
Immunol Cell Biol. 2019 Sep;97(8):700-713
pubmed: 30989674
PLoS One. 2018 Dec 3;13(12):e0208420
pubmed: 30507949
Front Immunol. 2017 Apr 03;8:341
pubmed: 28421070
Curr Opin Ophthalmol. 2017 Jan;27 Suppl 1:3-47
pubmed: 28099212
Cornea. 2007 Jan;26(1):47-54
pubmed: 17198013
Mucosal Immunol. 2017 Sep;10(5):1202-1210
pubmed: 28051088
Front Immunol. 2019 May 16;10:1088
pubmed: 31156637
Immunol Invest. 2012;41(6-7):738-64
pubmed: 23017144
Curr Opin Immunol. 2013 Jun;25(3):396-402
pubmed: 23725656
PLoS One. 2015 Mar 26;10(3):e0122184
pubmed: 25811482
Graefes Arch Clin Exp Ophthalmol. 2017 Sep;255(9):1771-1778
pubmed: 28528377
Int Immunopharmacol. 2016 May;34:1-15
pubmed: 26906720
Int J Mol Sci. 2018 Apr 17;19(4):null
pubmed: 29673232
J Leukoc Biol. 2003 Aug;74(2):172-8
pubmed: 12885933
Graefes Arch Clin Exp Ophthalmol. 2018 Dec;256(12):2449-2456
pubmed: 30073622
Br J Ophthalmol. 1994 May;78(5):381-5
pubmed: 8025072
Eye (Lond). 2014 May;28(5):608-13
pubmed: 24603428
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):5996-6002
pubmed: 27820631
Biomed Res Int. 2016;2016:5159746
pubmed: 27034940
Ocul Surf. 2014 Jan;12(1):23-31
pubmed: 24439044
Am J Ophthalmol. 2015 Jun;159(6):1022-1026.e2
pubmed: 25782347
Biomed Res Int. 2016;2016:4369750
pubmed: 26904676
Immunol Lett. 2014 Mar-Apr;158(1-2):73-8
pubmed: 24333339
Nat Immunol. 2015 May;16(5):448-57
pubmed: 25898198
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Nat Rev Immunol. 2013 Aug;13(8):566-77
pubmed: 23827956
Semin Immunol. 2005 Aug;17(4):273-83
pubmed: 15953735
Clin Ophthalmol. 2012;6:511-9
pubmed: 22536045
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7783-8
pubmed: 16672373
Ophthalmic Res. 2019;61(1):51-59
pubmed: 29627838
Invest Ophthalmol Vis Sci. 2011 Jul 11;52(8):5136-43
pubmed: 21460259
Ophthalmology. 1991 Apr;98(4):472-9
pubmed: 1828871
Eye Contact Lens. 2008 May;34(3):169-73
pubmed: 18463483
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4686-91
pubmed: 27607414
Front Immunol. 2018 Jul 31;9:1751
pubmed: 30108585
Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5457-5469
pubmed: 27760272
Immunity. 2017 Mar 21;46(3):504-515
pubmed: 28329707
Eur J Immunol. 2017 Oct;47(10):1798-1801
pubmed: 28845904
Br J Ophthalmol. 1999 Dec;83(12):1364-9
pubmed: 10574815
Cont Lens Anterior Eye. 2016 Aug;39(4):307-10
pubmed: 26923921
Sci Rep. 2017 Mar 27;7:45312
pubmed: 28345628
Microbes Infect. 2003 Jan;5(1):59-67
pubmed: 12593974
Nature. 1979 Nov 15;282(5736):324-6
pubmed: 503208
Acta Ophthalmol Scand. 2005 Apr;83(2):234-9
pubmed: 15799739
Immunology. 2013 Sep;140(1):22-30
pubmed: 23621371
Invest Ophthalmol Vis Sci. 2014 Oct 16;55(11):7457-66
pubmed: 25324281
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):643-50
pubmed: 19850844

Auteurs

Amaya Pérez Del Palomar (APD)

Mechanical Engineering Department, University of Zaragoza, 50009 Zaragoza, Spain.
Biomaterials Group, Aragon Institute of Engineering Research, University of Zaragoza, 50009 Zaragoza, Spain.

Alberto Montolío (A)

Mechanical Engineering Department, University of Zaragoza, 50009 Zaragoza, Spain.
Biomaterials Group, Aragon Institute of Engineering Research, University of Zaragoza, 50009 Zaragoza, Spain.

José Cegoñino (J)

Mechanical Engineering Department, University of Zaragoza, 50009 Zaragoza, Spain.
Biomaterials Group, Aragon Institute of Engineering Research, University of Zaragoza, 50009 Zaragoza, Spain.

Sandeep Kumar Dhanda (SK)

La Jolla Institute for Immunology, La Jolla, CA 92037, USA.

Chit Tong Lio (CT)

Chair of Experimental Bioinformatics, Technical University of Munich (TUM), 85354 Freising-Weihenstephan, Germany.

Tanima Bose (T)

Institute for Clinical Neuroimmunology, Ludwig Maximilian University of Munich (LMU), 82152 München, Germany.

Classifications MeSH